1-248473425-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005495.1(OR2T3):āc.75G>Cā(p.Glu25Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,505,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005495.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T3 | NM_001005495.1 | c.75G>C | p.Glu25Asp | missense_variant | 1/1 | ENST00000359594.3 | NP_001005495.1 | |
LOC105373279 | XR_007067006.1 | n.136-3266C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T3 | ENST00000359594.3 | c.75G>C | p.Glu25Asp | missense_variant | 1/1 | 6 | NM_001005495.1 | ENSP00000352604.2 |
Frequencies
GnomAD3 genomes AF: 0.0000347 AC: 5AN: 144070Hom.: 0 Cov.: 24
GnomAD3 exomes AF: 0.0000176 AC: 4AN: 227640Hom.: 0 AF XY: 0.0000245 AC XY: 3AN XY: 122330
GnomAD4 exome AF: 0.0000213 AC: 29AN: 1361030Hom.: 0 Cov.: 26 AF XY: 0.0000279 AC XY: 19AN XY: 680578
GnomAD4 genome AF: 0.0000347 AC: 5AN: 144070Hom.: 0 Cov.: 24 AF XY: 0.0000429 AC XY: 3AN XY: 69850
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.75G>C (p.E25D) alteration is located in exon 1 (coding exon 1) of the OR2T3 gene. This alteration results from a G to C substitution at nucleotide position 75, causing the glutamic acid (E) at amino acid position 25 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at